Latest close: security removed from listing or deregisteredSep 8, 2026what changed →2024-08-08$25.56 – $84.96 · dashed line: 200-day average2026-08-31
What is the market doing?
What the tape says about CRNX
Crinetics Pharmaceuticals, Inc. is +13% over the past year while the S&P 500 is +20%: 7.3 points behind the market.
+13%
1-year return · S&P 500 +20%
- vs 200-day average
- +73%
vs 200-day average · a clear uptrend
- RSI (14)
- 90
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- 0.00%
Below its 52-week high
Details›
- Last close2026-08-31
- $34.99
- 1 monthS&P 500 −0.30%
- −4.9%
- 1 yearS&P 500 +20%
- +13%
- 5 yearsS&P 500 +85%
- +81%
- vs 50-day average$67.34
- +26%
- 52-week high
- $84.96
- 52-week low
- $28.48
- Annualised volatility
- 111%
| Year | Return |
|---|---|
| 2026 (year to date) | +83% |
| 2025 | −9.0% |
| 2024 | +44% |
| 2023 | +94% |
| 2022 | −36% |
| 2021 | +101% |
| 2020 | −44% |
| 2019 | −16% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 4 of 8 | −7.8% |
| Feb | 8 | 4 of 8 | −2.2% |
| Mar | 8 | 2 of 8 | −5.7% |
| Apr | 8 | 5 of 8 | +6.9% |
| May | 8 | 4 of 8 | −2.6% |
| Jun | 8 | 4 of 8 | −0.35% |
| Jul | 8 | 4 of 8 | +15% |
| Aug | 9 | 5 of 9 | +5.1% |
| Sep | 8 | 3 of 8 | +10% |
| Oct | 8 | 4 of 8 | +0.75% |
| Nov | 8 | 7 of 8 | +10% |
| Dec | 8 | 6 of 8 | +3.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.